Aspire-Lakewood Holdings Inc
ASBPConsumer Cyclical·Auto Parts·USA·Nano·NASD·Nov 11 • 2:12 PM ET
8.90+0.39 (4.58%)
2026-11-11 20:18 CET
Market cap
11.94 USD m
Revenue, TTM
0.10 USD m
Net income, TTM
-11.05 USD m
Free cash flow, TTM
-7.19 USD m
EPS diluted, TTM
-106.59
P/E
-
Price
ASBP against its 20, 50 and 200-day averages2050200
95.7% under the 52-week high of 205.20 on 7 Jan 2026. 52-week low 3.31 on 8 May 2026. Last 15 sessions, 36.4% high to low
Profile
ASBP52-week range, 3% of the way up
3.31205.2
Aspire-Lakewood Holdings, Inc. operates as a biopharmaceutical company that engages in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company was founded on February 2, 2025 and is headquartered in Estero, FL.
| IPO | Apr 11, 2022 |
|---|---|
| Beta | 0.15 |
| ATR, 14d | 0.65 |
| Rel volume | 0.79 |
| Short float | 0.53% |
| Insider own | 20.10% |
| Inst own | 5.72% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | 12.49M |
| Enterprise Value | 0.32M |
| Income | -11.05M |
| Sales | 0.10M |
| Book/sh | 9.08 |
| Cash/sh | 8.68 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | - |
| IPO | Apr 11, 2022 |
Ratios
| P/E | - |
|---|---|
| Forward P/E | - |
| PEG | - |
| P/S | 124.87 |
| P/B | 0.98 |
| P/C | 1.03 |
| P/FCF | - |
| EV/EBITDA | - |
| EV/Sales | 3.17 |
| Quick Ratio | 7.81 |
| Current Ratio | 7.99 |
| Debt/Eq | 0.00 |
| LT Debt/Eq | 0.00 |
| Option/Short | No / Yes |
Earnings
| EPS (ttm) | -106.59 |
|---|---|
| EPS next Y | - |
| EPS next Q | - |
| EPS this Y | - |
| EPS next Y | - |
| EPS next 5Y | - |
| EPS past 3/5Y | - - |
| Sales past 3/5Y | - - |
| EPS Y/Y TTM | 94.71% |
| Sales Y/Y TTM | - |
| EPS Q/Q | 97.46% |
| Sales Q/Q | - |
| Earnings | - |
| EPS/Sales Surpr. | - - |
Ownership
| Insider Own | 20.10% |
|---|---|
| Insider Trans | 0.00% |
| Inst Own | 5.72% |
| Inst Trans | 18.13% |
| ROA | -152.09% |
| ROE | -1032.14% |
| ROIC | -93.97% |
| Gross Margin | 18.35% |
| Oper. Margin | -7259.85% |
| Profit Margin | -11314.12% |
| SMA20 | 7.40% |
| SMA50 | 5.19% |
| SMA200 | -41.50% |
| Trades | - |
Technical
| Shs Outstand | 1.30M |
|---|---|
| Shs Float | 1.12M |
| Short Float | 0.53% |
| Short Ratio | 0.19 |
| Short Interest | 0.01M |
| 52W High | 205.20 -95.66% |
| 52W Low | 3.31 169.11% |
| Volatility | 10.27% 8.70% |
| ATR (14) | 0.65 |
| RSI (14) | 57.04 |
| Beta | 0.15 |
| Rel Volume | 0.79 |
| Avg Volume | 30.38K |
| Volume | 18,090 |
Performance
| Perf Week | 21.82% |
|---|---|
| Perf Month | 8.86% |
| Perf Quarter | 25.25% |
| Perf Half Y | 68.02% |
| Perf YTD | -94.37% |
| Perf Year | -93.61% |
| Perf 3Y | -99.93% |
| Perf 5Y | - |
| Perf 10Y | - |
| Recom | - |
| Target Price | - |
| Prev Close | 8.52 |
| Price | 8.90 |
| Change % | 4.58% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| SRI | Stoneridge Inc | 146.48M |
| CVGI | Commercial Vehicle Group Inc | 130.56M |
| SYPR | Sypris Solutions Inc | 27.86M |
| THRM | Gentherm Inc | 1.57B |
| MPAA | Motorcar Parts of America Inc | 144.44M |
| AETR | Aetherion Technologies Inc | 35.15M |
| CAAS | China Automotive Systems Inc | 133.96M |
| GTEC | Greenland Technologies Holding Corp | 13.52M |
| PRTS | CarParts.com Inc | 67.82M |
| LPCN | Lipocine Inc | 17.72M |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VXF | Vanguard Extended Market Index ETF | AUM: 30.47B |
News
latest 14 of 184- Aspire-Lakewood Holdings Board Approves $10 Million Share Repurchase Program (ACCESSWIRE)
- Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc. (ACCESSWIRE)
- Sidoti Events, LLC's August Micro-Cap Virtual Conference (ACCESSWIRE)
- Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th (ACCESSWIRE)
- Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue (ACCESSWIRE)
- Freestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma's BUZZ BOMB(TM) (ACCESSWIRE) +5.45%
- Aspire Biopharma's BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick Packs (ACCESSWIRE) +6.00%
- Aspire Biopharma Acquires Automotive Supplier Dura Driver Control Systems in $30M Deal (ASBP) (InvestorsHub) -17.33%
- ASBP Stock Heads For Best Week In Over 2 Months Why This Drug Delivery Tech Firm Is Buying An Auto Supplier? (Stocktwits)
- Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue (ACCESSWIRE)
- Aspire Biopharma Issues Shareholder Letter (ACCESSWIRE) +18.42%
- Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members (ACCESSWIRE) -7.89%
- Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio (ACCESSWIRE) -16.67%
- BC-Most Active Stocks (Associated Press)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| No quarterly earnings. | |||||||
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| No annual earnings. | |||||
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| No estimate revisions. | ||||||||
Estimate history
| EPS, annual | - | 111.54 | 279.312 | -56.964 | -491.268 | -106.5948 | |||
|---|---|---|---|---|---|---|---|---|---|
| Period | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | |||
| EPS, quarterly | -85.368 | -82.992 | -1380.18 | -504.864 | -48.192 | -44.832 | -39.972 | -20.569 | -1.222 |
| Period | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
| Sales, annual | 0 | 0 | 0 | 0 | 0.006 | 0.1 | |||
| Period | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | |||
| Sales, quarterly | 0 | 0 | 0 | 0 | 0 | 0.002 | 0.004 | 0.028 | 0.063 |
| Period | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
| Shares, annual | 0.026 | 0.03 | 0.007 | 0.023 | 0.118 | 1.295 | |||
| Period | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ | |||
| Shares, quarterly | 0.006 | 0.006 | 0.006 | 0.041 | 0.041 | 0.041 | 0.118 | 0.167 | 1.295 |
| Period | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY |
|---|---|---|---|---|---|---|
| Total Revenue | 0.10 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 0.08 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.02 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling, General and Administrative Excl. Other | 7.07 | 19.35 | 1.21 | 1.34 | 0.98 | 0.03 |
| Research and Development | 0.84 | 0.92 | 0.14 | - | - | - |
| Other Operating Expense | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -7.09 | -19.35 | -1.21 | -1.34 | -0.98 | -0.03 |
| Interest Expense | - | 8.53 | 0.10 | 0.01 | 0.00 | - |
| Unusual Expense | -5.29 | -3.40 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -11.05 | -24.48 | -1.31 | 4.46 | 3.34 | -0.03 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -11.05 | -24.48 | -1.31 | 4.46 | 3.34 | -0.03 |
| Net Income From Continuing Operations | -11.05 | -24.48 | -1.31 | 4.46 | 3.34 | -0.03 |
| Net Income | -11.05 | -24.48 | -1.31 | 4.46 | 3.34 | -0.03 |
| EPS (Recurring) | -14.21 | -539.05 | -56.96 | 279.31 | 111.53 | - |
| EPS (Basic, Before Extraordinaries) | -106.59 | -491.27 | -56.96 | 279.31 | 111.54 | - |
| EPS (Diluted) | -106.59 | -491.27 | -56.96 | 279.31 | 111.54 | - |
| EBITDA | -7.09 | -19.35 | -1.21 | -1.34 | -0.98 | -0.03 |
| Non-Operating Income (Expense) | 0.06 | 0.00 | 0.00 | 5.81 | 4.32 | 0.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | - | 14.13 | - | - | - | - |
| Price To Earnings Ratio | - | - | - | 56.91 | - | - |
| Price To Sales Ratio | 56.75 | 1,271.75 | - | - | - | - |
| Gross Margin | 18.35 | -1.87 | - | - | - | - |
| Operating Margin | -7,259.85 | -312,016.95 | - | - | - | - |
| Net Margin | -11,314.12 | -394,725.06 | - | - | - | - |
| Shares Outstanding | 1.30 | 0.12 | 0.02 | 0.01 | 0.03 | 0.03 |
| Market Capitalization | 11.94 | 11.94 | 89.30 | 97.91 | 370.16 | 370.16 |
Income statement, quarterly
| Metric | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.06 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 0.05 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.01 | 0.01 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling, General and Administrative Excl. Other | 2.42 | 1.65 | 1.85 | 1.15 | 0.80 | 15.56 | - | 0.63 |
| Research and Development | 0.23 | 0.30 | 0.10 | 0.21 | 0.35 | 0.26 | - | - |
| Other Operating Expense | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.45 | -1.65 | -1.85 | -1.15 | -0.80 | -15.56 | 0.00 | -0.63 |
| Interest Expense | - | 1.60 | 6.23 | 1.48 | 0.53 | 0.29 | 0.49 | 0.01 |
| Unusual Expense | -1.12 | -0.01 | -3.38 | -0.78 | 0.65 | 0.09 | 8.71 | 0.01 |
| Net Income Before Taxes | -1.27 | -3.22 | -4.71 | -1.85 | -1.98 | -15.94 | -8.93 | -0.54 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -1.27 | -3.22 | -4.71 | -1.85 | -1.98 | -15.94 | -8.93 | -0.54 |
| Net Income From Continuing Operations | -1.27 | -3.22 | -4.71 | -1.85 | -1.98 | -15.94 | -8.93 | -0.54 |
| Net Income | -1.27 | -3.22 | -4.71 | -1.85 | -1.98 | -15.94 | -8.93 | -0.54 |
| EPS (Recurring) | -1.98 | -20.63 | -60.03 | -57.98 | -37.07 | -502.77 | -438.42 | -82.07 |
| EPS (Basic, Before Extraordinaries) | -1.22 | -20.57 | -39.97 | -44.83 | -48.19 | -504.86 | -1,380.18 | -82.99 |
| EPS (Diluted) | -1.22 | -20.57 | -39.97 | -44.83 | -48.19 | -504.86 | -1,380.18 | -82.99 |
| EBITDA | -2.45 | -1.65 | -1.85 | -1.15 | -0.80 | -15.56 | 0.00 | -0.63 |
| Non-Operating Income (Expense) | 0.06 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.11 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 0.16 | 0.01 | -4E-06 | - | 14.13 | 14.13 | - | - |
| Price To Sales Ratio | 56.75 | 140.11 | 3,005.85 | 5,256.23 | - | - | - | - |
| Gross Margin | 19.47 | 20.28 | -23.47 | 45.54 | - | - | - | - |
| Operating Margin | -3,880.58 | -5,805.98 | -43,403.52 | -59,015.82 | - | - | - | - |
| Net Margin | -2,009.61 | -11,367.02 | -110,484.25 | -95,337.09 | - | - | - | - |
| Shares Outstanding | 1.30 | 0.17 | 0.12 | 0.04 | 0.04 | 0.04 | 0.01 | 0.01 |
| Market Capitalization | 11.94 | 5.17 | 18.64 | 10.20 | 13.32 | 28.49 | 89.30 | 94.81 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY |
|---|---|---|---|---|---|
| Cash & Short Term Investments | 1.00 | 0.00 | 0.00 | 0.50 | 0.00 |
| Short Term Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.06 | 0.14 | 0.08 | 0.60 | 0.00 |
| Total Current Assets | 1.31 | 0.15 | 0.08 | 1.10 | 0.00 |
| Net Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Investments and Advances | 0.00 | 0.00 | 19.90 | 299.00 | 0.00 |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.08 | 0.29 |
| Total Assets | 1.31 | 0.15 | 19.98 | 300.18 | 0.29 |
| Short Term Debt Incl. Current Port. of LT Debt | 5.18 | 1.27 | 0.01 | 0.00 | 0.24 |
| Accounts Payable | 1.01 | 0.31 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 1.40 | 0.11 | 0.39 | 0.30 | 0.06 |
| Total Current Liabilities | 7.59 | 1.69 | 0.40 | 0.30 | 0.29 |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.10 | 0.00 | 0.00 | 10.81 | 0.00 |
| Total Liabilities | 7.69 | 1.69 | 0.40 | 11.12 | 0.29 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | -6.38 | -1.54 | 19.58 | 289.07 | -0.00 |
| Total Shareholders Equity | -6.38 | -1.54 | 19.58 | 289.07 | -0.00 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | -6.38 | -1.54 | 19.58 | 289.07 | -0.00 |
| Total Liabilities & Stockholders Equity | 1.31 | 0.15 | 19.98 | 300.18 | 0.29 |
| Book Value Per Share | -54.14 | -66.96 | 2,613.09 | 9,652.30 | -0.02 |
| Tangible Book Value Per Share | -54.14 | -66.96 | 2,613.09 | 9,652.30 | -0.02 |
| Full-Time Employees | - | - | 2 | - | - |
| Price to Book Ratio | 0.94 | -10.03 | 5.00 | 1.29 | 1.29 |
| Return on Assets | -610.00 | -13.01 | 2.79 | 2.22 | - |
| Return on Equity | - | -14.52 | 2.89 | 2.31 | - |
| Return on Invested Capital | - | - | 22.80 | 1.16 | - |
| Quick Ratio | 0.14 | 0.09 | 0.20 | 3.62 | 0.00 |
| Current Ratio | 0.17 | 0.09 | 0.20 | 3.62 | 0.00 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY |
|---|---|---|---|---|---|---|
| Net Income | -11.05 | -24.48 | -1.31 | 4.46 | 3.34 | -0.03 |
| Other Funds (Non Cash) | 3.75 | 19.02 | 0.00 | -5.80 | -4.32 | 0.00 |
| Funds from Operations | -7.30 | -5.46 | -1.31 | -1.34 | -0.98 | -0.03 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 0.11 | 0.53 | 1.04 | 0.69 | -0.43 | -0.21 |
| Cash from Operating Activities | -7.19 | -4.92 | -0.27 | -0.65 | -1.41 | -0.24 |
| Capital Expenditures | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | -294.69 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | -294.69 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 284.92 | 0.00 | 0.00 |
| Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 284.92 | -294.69 | 0.00 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 17.95 | 0.00 | 0.26 | -284.76 | 296.85 | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | -284.92 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 17.95 | 0.00 | 0.26 | 0.16 | 296.85 | 0.00 |
| Proceedsfrom Stock Options | 17.95 | 0.00 | 0.26 | 0.16 | 296.85 | 0.00 |
| Issuance or Reduction of Debt, Net | 1.91 | 6.57 | 0.00 | 0.00 | -0.25 | 0.24 |
| Change in Long Term Debt | -0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -2.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | -0.72 | -0.64 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | -0.98 | -0.91 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 19.15 | 5.92 | 0.26 | -284.76 | 296.59 | 0.24 |
| Net Change in Cash | 11.96 | 1.00 | -0.01 | -0.50 | 0.50 | - |
| Free Cash Flow | -7.19 | -4.92 | -0.27 | -0.65 | -1.41 | -0.24 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 12.17 | 5.86 | 1.00 | 1.95 | 0.21 | 1.35 |
| Short Term Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.29 | 0.37 | 0.25 | 0.04 | 0.00 | 0.00 |
| Other Current Assets | 1.01 | 0.89 | 0.06 | 0.42 | 0.78 | 0.62 |
| Total Current Assets | 13.47 | 7.12 | 1.31 | 2.40 | 0.99 | 1.97 |
| Net Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | 13.54 | 7.12 | 1.31 | 2.40 | 0.99 | 1.97 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.00 | 1.50 | 5.18 | 8.62 | 8.47 | 6.76 |
| Accounts Payable | 0.97 | 0.86 | 1.01 | 1.06 | 1.35 | 1.43 |
| Other Current Liabilities | 0.71 | 0.80 | 1.40 | 4.17 | 0.73 | 0.67 |
| Total Current Liabilities | 1.69 | 3.15 | 7.59 | 13.86 | 10.56 | 8.87 |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.10 | 0.10 | 0.10 | 0.01 | 0.05 | 0.05 |
| Total Liabilities | 1.78 | 3.25 | 7.69 | 13.87 | 10.61 | 8.92 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 2E-06 | 1E-06 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 11.76 | 3.87 | -6.38 | -11.47 | -9.62 | -6.95 |
| Total Shareholders Equity | 11.76 | 3.87 | -6.38 | -11.47 | -9.62 | -6.95 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 11.76 | 3.87 | -6.38 | -11.47 | -9.62 | -6.95 |
| Total Liabilities & Stockholders Equity | 13.54 | 7.12 | 1.31 | 2.40 | 0.99 | 1.97 |
| Book Value Per Share | 9.08 | 23.10 | -54.14 | -277.85 | -233.01 | -170.62 |
| Tangible Book Value Per Share | 9.08 | 23.10 | -54.14 | -277.85 | -233.01 | -170.62 |
| Price to Book Ratio | 0.94 | 1.34 | -2.92 | -0.89 | -1.39 | -4.10 |
| Return on Assets | -152.09 | -259.01 | -610.00 | -633.21 | -697.23 | -234.69 |
| Return on Equity | -1,032.14 | - | - | - | - | -490.07 |
| Return on Invested Capital | -10.79 | -83.31 | - | - | - | - |
| Quick Ratio | 7.81 | 2.14 | 0.14 | 0.17 | 0.09 | 0.22 |
| Current Ratio | 7.99 | 2.26 | 0.17 | 0.17 | 0.09 | 0.22 |
Cash flow, quarterly
| Metric | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 |
|---|---|---|---|---|---|---|
| Net Income | -1.27 | -3.22 | -4.71 | -1.85 | -1.98 | -15.94 |
| Other Funds (Non Cash) | -1.17 | 1.59 | 2.90 | 0.43 | 1.18 | 14.52 |
| Funds from Operations | -2.44 | -1.63 | -1.81 | -1.42 | -0.80 | -1.43 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 0.32 | -1.41 | 0.88 | 0.32 | -0.34 | -0.33 |
| Cash from Operating Activities | -2.12 | -3.04 | -0.93 | -1.10 | -1.14 | -1.75 |
| Capital Expenditures | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | - | - |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 9.00 | 8.95 | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 9.00 | 8.95 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 9.00 | 8.95 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -0.67 | -0.89 | 0.63 | 2.85 | 0.00 | 3.09 |
| Change in Long Term Debt | -0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -2.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.10 | -0.17 | -0.64 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 2.10 | -2.17 | -0.91 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 8.43 | 7.89 | -0.02 | 2.85 | 0.00 | 3.09 |
| Net Change in Cash | 6.31 | 4.85 | -0.94 | 1.74 | -1.14 | 1.34 |
| Free Cash Flow | -2.12 | -3.04 | -0.93 | -1.10 | -1.14 | -1.75 |
Revenue breakdown
| Pharmaceutical Preparations | 2025: 6.20K |
|---|---|
| Canada | 2025: 30 |
| United Kingdom | 2025: 19 |
| United States | 2025: 6.15K |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 0.53% | 0.0M | 1.1M | 31.41K |
| 2026-10-15 | 0.78% | 0.0M | 1.1M | 37.27K |
| 2026-09-30 | 1.21% | 0.0M | 1.1M | 40.96K |
| 2026-09-15 | 3.10% | 0.0M | 1.1M | 61.33K |
| 2026-08-31 | 3.93% | 0.0M | 1.1M | 273.62K |
| 2026-08-14 | 6.01% | 0.1M | 1.1M | 387.70K |
| 2026-07-31 | 6.55% | 0.1M | 1.2M | 505.43K |
| 2026-07-15 | 9.70% | 0.1M | 1.2M | 818.84K |
| 2026-06-30 | 8.31% | 0.1M | 1.2M | 799.90K |
| 2026-06-15 | 26.40% | 0.3M | 1.3M | 767.66K |
| 2026-05-29 | 10.24% | 0.1M | 1.2M | 557.53K |
| 2026-05-15 | 6.28% | 0.1M | 1.2M | 446.28K |
| 2026-04-30 | 17.55% | 0.0M | 0.2M | 333.75K |
| 2026-04-15 | 7.98% | 0.0M | 0.2M | 28.07K |
| 2026-03-31 | 9.62% | 0.0M | 0.1M | 36.26K |
| 2026-03-13 | 11.17% | 0.0M | 0.1M | 33.31K |
| 2026-02-27 | 8.96% | 0.0M | 0.1M | 34.65K |
| 2026-02-13 | 16.75% | 0.0M | 0.1M | 46.63K |
| 2026-01-30 | 22.45% | 0.0M | 0.1M | 44.54K |
| 2026-01-15 | 23.60% | 0.0M | 0.1M | 34.53K |
Option chain
expiry 2026-11-11| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-05 | SCHEDULE 13G | SEC | ||
| 2026-10-20 | 8-K/A | 2026-08-06 | SEC | |
| 2026-09-29 | 8-K | Current report | 2026-09-24 | SEC |
| 2026-09-09 | 8-K | Current report | 2026-09-08 | SEC |
| 2026-09-08 | 8-K | Current report | 2026-09-08 | SEC |
| 2026-08-19 | 8-K | Current report | 2026-08-19 | SEC |
| 2026-08-14 | SCHEDULE 13G/A | SEC | ||
| 2026-08-13 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-10 | 8-K | Current report | 2026-08-06 | SEC |
| 2026-08-10 | SCHEDULE 13G | SEC | ||
| 2026-08-06 | SCHEDULE 13G/A | SEC | ||
| 2026-07-20 | 8-K | Current report | 2026-07-20 | SEC |
| 2026-07-02 | SCHEDULE 13G | SEC | ||
| 2026-06-22 | 8-K | Current report | 2026-06-16 | SEC |
| 2026-06-12 | 8-K | Current report | 2026-06-09 | SEC |
| 2026-06-12 | 8-K | Current report | 2026-06-12 | SEC |
| 2026-05-15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-03-31 | SEC |
| 2026-05-15 | SCHEDULE 13G | SEC | ||
| 2026-05-14 | 8-K | Current report | 2026-05-11 | SEC |
| 2026-05-13 | SCHEDULE 13G/A | SEC | ||
| 2026-05-12 | DEFR14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | SEC | |
| 2026-05-08 | DEF 14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | 2026-05-08 | SEC |
| 2026-04-27 | PRE 14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | 2026-04-27 | SEC |
| 2026-04-20 | 8-K | Current report | 2026-04-20 | SEC |
| 2026-04-17 | 8-K/A | 2026-04-15 | SEC | |
| 2026-04-16 | 8-K | Current report | 2026-04-15 | SEC |
| 2026-04-16 | 8-K | Current report | 2026-04-10 | SEC |
| 2026-04-16 | 8-K | Current report | 2026-04-16 | SEC |
| 2026-04-15 | 8-K | Current report | 2026-04-15 | SEC |
| 2026-04-14 | EFFECT | Effectiveness filing by commission order | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| FNY Investment Advisers, LLC | 1.98% |
| JANE STREET GROUP, LLC | 1.14% |
| GEODE CAPITAL MANAGEMENT, LLC | 1.14% |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.80% |
| VANGUARD FIDUCIARY TRUST CO | 0.78% |
| Crewe Advisors LLC | 0.05% |
| Tower Research Capital LLC | 0.02% |
| TORONTO DOMINION BANK | 0.01% |
| Avion Wealth | 0.00% |
| VALLEY WEALTH MANAGERS, INC. | 0.00% |
Funds
| Fund | % owned |
|---|---|
| - | |
OakChart. ASBP. Cached 15 minutes.
Some panels did not load: ratings, insider.